CClinicalTrials.gg
Status unknownNCT03443778Updated Feb 23, 2018

Dexamethasone-bupivacaine Versus Bupivacaine for Tonsillectomy Pain.

A Phase 4 interventional study of Bupivacaine 0.5% and Bupivacaine 0.5% , Dexamethasone in Tonsillectomy, sponsored by Sisli Hamidiye Etfal Training and Research Hospital. Status unknown at 1 site in Turkey. Open to participants aged 2 Years to 12 Years. Per ClinicalTrials.gov, last updated 2018-02-23.

Sponsored by Sisli Hamidiye Etfal Training and Research Hospital · Phase 4, Interventional, and Other

The sponsor has not verified this record recently (last verified Feb 2018), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Phase 4
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
2 Years to 12 Years
Sex
All
01

Study summary

Investigators compared in this study peritonsillar infiltration of bupivacaine %0.5 (n=40 participants) versus bupivacaine % 0.5 and dexamethasone (number 40participants ) before surgery for reduce posttonsillectomy pain.And control group (n= 40participants) participants received peritonsillar Nacl 0,9% .

Read the detailed description

Bupivacaine hydrochloride amid structure,long acting local anesthetic. Dexamethasone has strong anti-inflammatory drug reduce postoperative pain and nause and vomiting.Preoperative iv dexamethasone is routinely using for reduce tonsillectomy pain.Lots of studies show that adding dexamethasone to local anesthetic at peripheral nerve block prolongs the analgesic effect.Also preoperative iv dexamethasone prolongs the analgesic effects of local anesthetic infiltration .

Post tonsillectomy pain still a serious problem ,it effects postoperative morbidity.Different medicine combination used to applies for peritonsillar infiltration and multimodal iv and oral medication to reduce posttonsillectomy pain.İn this study investigators will use iv dexamethasone for all participants and investigators hypothesis that adding dexamethasone to bupivacaine for peritonsillar infiltration will reduce postoperative pain scores , consumption of rescue analgesic ,patient and family satisfaction.

02

Conditions studied

  • Tonsillectomy

Keywords

  • tonsillectomy pain
  • dexamethasone
  • bupivacaine
03

Who can participate

Ages eligible
2 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

Tonsillectomy surgery for recurrent tonsillitis Sleep disorder breathing

Exclusion criteria

ExclusionCriteria:

Patients with active upper respiratory tract infection Patients with significant cognitive impairment Bupivacaine hypersensitivity Dexamethasone hypersensitivity Taking chronic systemic steroids

04

Study design

Phase
Phase 4
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
120 participants (estimated)

Study arms

  • Active comparator
    Nacl 0,9% (Control) group

    Nacl 0,9% 3-5 ml separately two part for each tonsil before surgery

    Drug: Nacl 0,9 %

  • Active comparator
    Bupivacaine 0,5%

    Bupivacaine 0.5% 1 mg/kg with in Nacl 0,9% 3-5 ml separately two part for each tonsil before surgery

    Drug: Bupivacaine 0.5%

  • Active comparator
    Bupivacaine 0,5% , Dexamethasone

    Bupivacaine 0,5% 1 mg/kg,dexamethasone 0.5 mg/kg (max dosage 8mg) 3-5 ml separately two part for each tonsil before surgery

    Drug: Bupivacaine 0.5% , Dexamethasone

Interventions

  • DrugBupivacaine 0.5%

    Marcaine 0.5% Injectable Solution

    Also known as: Marcaine 0,5%

  • DrugBupivacaine 0.5% , Dexamethasone

    Bupivacaine 0.5% , Dexamethasone

    Also known as: Dekort, Marcaine 0,5 % Injectable Solution

  • DrugNacl 0,9 %

    Injectable Solution

    Also known as: Serum Physiologic

05

What researchers measure

Primary outcomes

  1. Incidence of moderate/severe pain(>/= 4 of 10 Pain Scores)

    Pain Scores will measure ; Face, Leg, Activity, Cry, Consolability score (FLACC) Interpreting the Score 0 Relaxed \& comfortable 1 - 3 = Mild discomfort 4 - 6 = Moderate pain 7 -10 = Severe pain or discomfort or both . 0 score is the best ,10 score is the worse score. 4 and up scores will considered to be the range to be treated .Pain score will measure at home ; Face Pain Scale 0 no pain 10 worse pain. Every day in the morning after phone call pain scores will ask patient/patient guardians. 4 and up scores will treated

    Time frame: postoperative 7day .

Secondary outcomes

  1. Side effects (nause,vomiting)

    Nause will measure with visual analog scale (VAS) . 0 is the best 10 is the worse score. vomiting will measure with present/absent

    Time frame: postop seven day

  2. Rescue analgesic consumption at PACU (post-anaesthesia care unit)

    Pain Scores will measure ; Face, Leg, Activity, Cry, Consolability score (FLACC) Interpreting the Score 0 Relaxed \& comfortable 1 - 3 = Mild discomfort 4 - 6 = Moderate pain 7 -10 = Severe pain or discomfort or both . 0 score is the best ,10 score is the worse score. 4 and up scores will considered to be the range to be treated with iv paracetamol (10 mg/kg maximum Daily dosage) . İf the pain score is still 4 and up it will treated with tramadol 1 mg/kg).

    Time frame: At Pacu 1 hour

  3. Rescue analgesic consumption first day at hospital

    Pain Scores will measure ; Face, Leg, Activity, Cry, Consolability score (FLACC) Interpreting the Score 0 Relaxed \& comfortable 1 - 3 = Mild discomfort 4 - 6 = Moderate pain 7 -10 = Severe pain or discomfort or both . 0 score is the best ,10 score is the worse score. 4 and up scores will treated with oral paracetamol (10 mg/kg)

    Time frame: 4,8,12,24 h at hospital in first postoperative day.

  4. Rescue analgesic consumption at home

    Pain Scores will measure ; Face Pain Scale 0 no pain 10 worse pain. 4 and up scores will treated with oral paracetamol (10 mg/kg)

    Time frame: postop 2-3-5-6- 7. day

  5. Parents satisfaction

    Parents satisfaction will measure visual analog scale (VAS) . 0 is the best 10 is the worse score.

    Time frame: postop seven day

06

Study locations

1 site
  • Leyla Kilinc
    İstanbul, Sisli 34360, Turkey
07

References and documents

Publications

  • Bayram A, Dogan M, Cihan C, Karatas D, Gokahmetoglu G, Ozcan I. The Efficacy of Levobupivacaine Hydrochloride-Dexamethasone Infiltration for Post-Tonsillectomy Pain in Adults. J Craniofac Surg. 2015 Oct;26(7):e651-3. doi: 10.1097/SCS.0000000000001975. PubMed 26468853 ↗
  • Basuni AS, Ezz HA, Albirmawy OA. Preoperative peritonsillar infiltration of dexamethasone and levobupivacaine reduces pediatric post-tonsillectomy pain: a double-blind prospective randomized clinical trial. J Anesth. 2013 Dec;27(6):844-9. doi: 10.1007/s00540-013-1638-0. Epub 2013 May 25. PubMed 23708881 ↗

Individual participant data

Plan to share: No — There is no plan to make individual participant (IPD) to the other researchers

08

Registry details

Key details

Study ID
NCT03443778
Lead sponsor
Sisli Hamidiye Etfal Training and Research Hospital
Responsible party
Leyla Kılınc (Principal investigator, Sisli Hamidiye Etfal Training and Research Hospital) — Principal investigator
First posted
Feb 23, 2018
Start date
Dec 15, 2017
Primary completion
Mar 15, 2018 (estimated)
Completion
Apr 15, 2018 (estimated)
Last update
Feb 23, 2018

Study contacts

Leyla Kilinc, Md
study director · Md

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion